Kurin Inc.

Kurin, Inc. is a San Diego-based certified Minority Business Enterprise (MBE) that specializes in innovative medical devices aimed at reducing contaminated blood cultures in healthcare settings. The company is privately held and employs around 32 people, reporting revenues of $6.8 million with notable growth in recent quarters. Kurin's primary product is the Kurin® blood culture collection set, which includes the Kurin Lock® designed to passively divert skin contaminants during blood collection. This device helps address the issue of false positive blood cultures, which can lead to unnecessary treatments and complications. The product has received FDA 510(k) market clearance and offers a user-friendly solution that does not require changes in clinician practices. Kurin collaborates with healthcare institutions like Crouse Hospital and The Ohio State University Wexner Medical Center to enhance patient safety and improve blood culture accuracy. In 2023, the company was recognized as Diverse Supplier of the Year by Vizient and has successfully navigated patent litigation, reinforcing its position in the market.